6RZ7

Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2570366 (F222 space group)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.43 Å
  • R-Value Free: 0.259 
  • R-Value Work: 0.229 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.

Gusach, A.Luginina, A.Marin, E.Brouillette, R.L.Besserer-Offroy, E.Longpre, J.M.Ishchenko, A.Popov, P.Patel, N.Fujimoto, T.Maruyama, T.Stauch, B.Ergasheva, M.Romanovskaia, D.Stepko, A.Kovalev, K.Shevtsov, M.Gordeliy, V.Han, G.W.Katritch, V.Borshchevskiy, V.Sarret, P.Mishin, A.Cherezov, V.

(2019) Nat Commun 10: 5573-5573

  • DOI: 10.1038/s41467-019-13348-2
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • Cysteinyl leukotriene G protein-coupled receptors CysLT <sub>1 </sub> and CysLT <sub>2 </sub> regulate pro-inflammatory responses associated with allergic disorders. While selective inhibition of CysLT <sub>1 </sub>R has been used for treating asthma ...

    Cysteinyl leukotriene G protein-coupled receptors CysLT 1 and CysLT 2 regulate pro-inflammatory responses associated with allergic disorders. While selective inhibition of CysLT 1 R has been used for treating asthma and associated diseases for over two decades, CysLT 2 R has recently started to emerge as a potential drug target against atopic asthma, brain injury and central nervous system disorders, as well as several types of cancer. Here, we describe four crystal structures of CysLT 2 R in complex with three dual CysLT 1 R/CysLT 2 R antagonists. The reported structures together with the results of comprehensive mutagenesis and computer modeling studies shed light on molecular determinants of CysLTR ligand selectivity and specific effects of disease-related single nucleotide variants.


    Organizational Affiliation

    Institut de Biologie Structurale Jean-Pierre Ebel, Université Grenoble Alpes-Commissariat à l'Energie Atomique et aux Energies Alternatives-CNRS, Grenoble, France.,Research Сenter for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Russia, 141701. mishinalexej@gmail.com.,JuStruct: Jülich Center for Structural Biology, Research Center Jülich, Jülich, Germany.,Bridge Institute, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, 90089, USA. cherezov@usc.edu.,Department of Chemistry, University of Southern California, Los Angeles, CA, 90089, USA.,Institute of Complex Systems (ICS), ICS-6: Structural Biochemistry, Research Center Jülich, Jülich, Germany.,Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka, 618-8585, Japan.,Research Сenter for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Russia, 141701.,Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada.,Merck Research Laboratories, Merck & Co Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA.,Department of Chemistry, University of Southern California, Los Angeles, CA, 90089, USA. cherezov@usc.edu.,Research Сenter for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Russia, 141701. cherezov@usc.edu.,Bridge Institute, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, 90089, USA.,Institute of Crystallography, RWTH Aachen University, Aachen, Germany.,Center for Computational and Data Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30, Building 1, Moscow, Russia, 121205.,Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada. Philippe.Sarret@USherbrooke.ca.,Department of Biological Sciences, University of Southern California, Los Angeles, CA, 90089, USA. cherezov@usc.edu.,CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.,Department of Biological Sciences, University of Southern California, Los Angeles, CA, 90089, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2
A
405Escherichia coliHomo sapiens
This entity is chimeric
Mutation(s): 6 
Gene Names: cybC, CYSLTR2 (CYSLT2, CYSLT2R)
Find proteins for P0ABE7 (Escherichia coli)
Go to UniProtKB:  P0ABE7
Find proteins for Q9NS75 (Homo sapiens)
Go to Gene View: CYSLTR2
Go to UniProtKB:  Q9NS75
Small Molecules
Ligands 5 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
KNW
Query on KNW

Download SDF File 
Download CCD File 
A
(2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid
ONO-2570366
C30 H30 Cl F N2 O7
JCUVQOJHURMRKB-SANMLTNESA-N
 Ligand Interaction
OLC
Query on OLC

Download SDF File 
Download CCD File 
A
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate
1-Oleoyl-R-glycerol
C21 H40 O4
RZRNAYUHWVFMIP-GDCKJWNLSA-N
 Ligand Interaction
OLA
Query on OLA

Download SDF File 
Download CCD File 
A
OLEIC ACID
C18 H34 O2
ZQPPMHVWECSIRJ-KTKRTIGZSA-N
 Ligand Interaction
PGE
Query on PGE

Download SDF File 
Download CCD File 
A
TRIETHYLENE GLYCOL
C6 H14 O4
ZIBGPFATKBEMQZ-UHFFFAOYSA-N
 Ligand Interaction
CLR
Query on CLR

Download SDF File 
Download CCD File 
A
CHOLESTEROL
C27 H46 O
HVYWMOMLDIMFJA-DPAQBDIFSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.43 Å
  • R-Value Free: 0.259 
  • R-Value Work: 0.229 
  • Space Group: F 2 2 2
Unit Cell:
Length (Å)Angle (°)
a = 81.830α = 90.00
b = 142.070β = 90.00
c = 171.160γ = 90.00
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling
BUSTERrefinement
PHASERphasing
PHENIXrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Russian Science FoundationRussian Federation16-14-10273
National Institutes of Health/National Institute of General Medical SciencesUnited StatesR35 GM127086
Canadian Institutes of Health ResearchCanada--
Fonds de Recherche du Quebec - Nature et TechnologiesCanada--

Revision History 

  • Version 1.0: 2019-12-11
    Type: Initial release
  • Version 1.1: 2019-12-18
    Type: Database references